AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 191,981 | 184,154 | 189,077 | 194,845 | 215,601 |
| Marketable Securities | 76,111 | 88,205 | 98,230 | 95,618 | 91,332 |
| Receivables | 341 | 588 | 570 | 306 | 3,102 |
| Other current assets | 1,026 | 440 | 197 | 1,102 | 953 |
| TOTAL | $272,465 | $277,215 | $291,609 | $294,677 | $314,030 |
| Non-Current Assets | |||||
| PPE Net | 4,115 | 3,912 | 3,889 | 3,943 | 3,757 |
| Investments And Advances | 331 | 316 | 314 | 306 | 309 |
| Other Non-Current Assets | 2,101 | 2,117 | 2,220 | 2,270 | 1,921 |
| TOTAL | $6,547 | $6,345 | $6,423 | $6,518 | $5,986 |
| Total Assets | $279,012 | $283,560 | $298,032 | $301,195 | $320,016 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 337 | 333 | 335 | 656 | 339 |
| Accounts payable and accrued liabilities | 1,109 | 1,496 | 786 | 143 | 0 |
| Accrued Expenses | 11,956 | 9,691 | 9,466 | 11,874 | 8,678 |
| Other current liabilities | N/A | N/A | 130 | N/A | N/A |
| TOTAL | $15,056 | $13,435 | $13,703 | $17,624 | $14,219 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,174 | 1,460 | 2,535 | 4,506 | 4,771 |
| Other Non-Current Liabilities | 10,351 | 9,805 | 9,698 | 9,358 | 7,677 |
| TOTAL | $10,351 | $9,805 | $9,698 | $9,358 | $9,087 |
| Total Liabilities | $25,407 | $23,240 | $23,401 | $26,982 | $23,306 |
| Shareholders' Equity | |||||
| Common Shares | 1,673 | 1,492 | 1,486 | 1,446 | 1,457 |
| Retained earnings | -125,081 | -100,875 | -85,206 | -76,012 | -56,354 |
| Other shareholders' equity | -109 | 0 | 0 | 0 | 0 |
| TOTAL | $253,605 | $260,320 | $274,631 | $274,213 | $296,710 |
| Total Liabilities And Equity | $279,012 | $283,560 | $298,032 | $301,195 | $320,016 |